Pillstats
Rx only · Injection, Solution · Intravenous

Rocuronium

Rocuronium Bromide

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)32521
US makers3 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.113$0.227$0.340$0.453Mar 2026Apr 2026Apr 2026
$0.394
Latest avg · Apr 22, 2026
+0%
Since Mar 18, 2026
3
Active US suppliers
75%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3266529781.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
691
Rx · 2026 Q1
3.5K
Units dispensed
-39%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Piramal Critical Care Incunknown2SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING
Medical Purchasing Solutions, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 15, 2023
    SHORTAGEDrug shortage: Rocuronium Bromide Injection (Piramal Critical Care Inc.)

    Rocuronium Bromide Injection — reported in shortage by Piramal Critical Care Inc.. Therapeutic category: Anesthesia.